RCC亚型与RAML运用CT诊断的价值分析
|
摘要
目的探析肾细胞癌(RCC)亚型与肾脏乏脂肪血管平滑肌脂肪瘤(RAML)运用CT诊断的价值。方法摘取2016年11月—2018年12月本院确诊的80例RCC亚型与40例RAML患者资料,所有患者均接受CT平扫及增强扫描,并对RCC亚型和RAML患者的CT值及肿瘤强化状况予以比较。结果平扫时嫌色细胞癌、乳头状细胞癌、透明细胞癌的CT值较RAML低(P <0.05);皮质期时嫌色细胞癌、乳头状细胞癌的CT值较RAML低,而透明细胞癌的CT值较RAML高(P <0.05);排泄期和实质期时嫌色细胞癌、乳头状细胞癌的CT值较RAML低,而RAML与透明细胞癌的CT值比较(P> 0.05)。RAML的均匀强化率较透明细胞癌高(P <0.05),而嫌色细胞癌、乳头状细胞癌比较(P> 0.05)。结论 CT扫描在RCC亚型与RAML中的鉴别诊断价值较高。
Objective To explore the value of CT in the diagnosis of RCC subtype and RAM. Methods A total of 80 patients with RCC subtypes and 40 RAML patients diagnosed in the hospital from November 2016 to December 2018 were enrolled. All patients underwent CT scan to enhanced scan, and the CT values and tumor enhancement in RCC subtype and RAML patients were compared. Results The CT values of chromophobe cell carcinoma, papillary cell carcinoma and clear cell carcinoma were lower than those of RAML(P<0.05). The CT values of chromophobe cell carcinoma and papillary cell carcinoma in cortex phase were lower than those of RAML, but the CT value of clear cell carcinoma was higher than that of RAML(P<0.05). The CT values of chromophobe cell carcinoma and papillary cell carcinoma were lower than those of RAML in excretion and parenchymal phases, while the CT value of clear cell carcinoma and that of RAML showed statistically significant difference(P>0.05). The uniform enhancement rate of RAML was higher than that of clear cell carcinoma(P<0.05), and it was of statistically significant difference compared with the rates of chromophobe cell carcinoma and papillary cell carcinoma(P>0.05).Conclusion CT scan is with higher value in the differential diagnosis of RCC subtype and RAML.
Objective To explore the value of CT in the diagnosis of RCC subtype and RAM. Methods A total of 80 patients with RCC subtypes and 40 RAML patients diagnosed in the hospital from November 2016 to December 2018 were enrolled. All patients underwent CT scan to enhanced scan, and the CT values and tumor enhancement in RCC subtype and RAML patients were compared. Results The CT values of chromophobe cell carcinoma, papillary cell carcinoma and clear cell carcinoma were lower than those of RAML(P<0.05). The CT values of chromophobe cell carcinoma and papillary cell carcinoma in cortex phase were lower than those of RAML, but the CT value of clear cell carcinoma was higher than that of RAML(P<0.05). The CT values of chromophobe cell carcinoma and papillary cell carcinoma were lower than those of RAML in excretion and parenchymal phases, while the CT value of clear cell carcinoma and that of RAML showed statistically significant difference(P>0.05). The uniform enhancement rate of RAML was higher than that of clear cell carcinoma(P<0.05), and it was of statistically significant difference compared with the rates of chromophobe cell carcinoma and papillary cell carcinoma(P>0.05).Conclusion CT scan is with higher value in the differential diagnosis of RCC subtype and RAML.
引文
[1]张莹,范锐,王俊勇,等.肾脏少脂肪血管平滑肌脂肪瘤患者21例临床分析并文献复习[J].河南外科学杂志,2015,21(5):15-16.
[2]王绎忱,周纯武,张连宇,等.DEAL-IQ技术结合纹理分析对肾脏少脂肪血管平滑肌脂肪瘤的鉴别诊断价值[J].放射学实践,2018,33(8):789-792.
[3]宋歌,王旭.直径≤3 cm肾脏富血供乏脂肪血管平滑肌脂肪瘤与透明细胞癌的CT鉴别分析[J].中国医药科学,2017,7(23):134-137.
[4]荆利民.CT在肾脏乏脂肪血管平滑肌脂肪瘤与肾细胞癌各亚型中的鉴别诊断价值分析[J].中国民康医学,2018,30(14):13-14.
[5]杨晓彤,赵宇,刘屹.能谱CT定量分析鉴别诊断肾透明细胞癌与肾脏乏脂肪血管平滑肌脂肪瘤的临床应用[J].临床军医杂志,2016,44(9):938-942.
[6]陈解南,张俊萍,刘铁峰,等.肾脏乏脂肪血管平滑肌脂肪瘤的临床病特征及CT表现[J].中国医学创新,2017,14(24):90-93.
[7]朱晓红,余永强,刘斌.乏脂肪肾脏血管平滑肌脂肪瘤与透明细胞癌的MSCT鉴别诊断[J].安徽医学,2017,38(6):766-768.
[8]黄丽军,张明波,陆志华.DWI在肾脏乏脂肪血管平滑肌脂肪瘤与透明细胞癌鉴别诊断的价值[J].中国CT与MRI杂志,2017,15(6):94-97.
[9]孟志华,黄钟情,周新,等.CT动态增强在肾脏乏脂肪血管平滑肌脂肪瘤与透明细胞癌中的鉴别诊断价值[J].汕头大学医学院学报,2017,30(4):228-229.
[10]尤国庆,李震,耿云平,等.乏脂肪型肾脏血管平滑肌脂肪瘤与肾脏透明细胞癌多排螺旋CT定量分析[J].实用医学杂志,2015,31(13):2151-2154.
[11]张爱伟,邱乾德,郑汉朋.肾脏乏脂肪血管平滑肌脂肪瘤的CT和MRI表现[J].医学影像学杂志,2014,24(2):268-271.
[12]卢贤忠,邓玉云,孟志华,等.肾脏乏脂肪血管平滑肌脂肪瘤的CT表现[J].中国当代医药,2017,24(18):63-65.
[2]王绎忱,周纯武,张连宇,等.DEAL-IQ技术结合纹理分析对肾脏少脂肪血管平滑肌脂肪瘤的鉴别诊断价值[J].放射学实践,2018,33(8):789-792.
[3]宋歌,王旭.直径≤3 cm肾脏富血供乏脂肪血管平滑肌脂肪瘤与透明细胞癌的CT鉴别分析[J].中国医药科学,2017,7(23):134-137.
[4]荆利民.CT在肾脏乏脂肪血管平滑肌脂肪瘤与肾细胞癌各亚型中的鉴别诊断价值分析[J].中国民康医学,2018,30(14):13-14.
[5]杨晓彤,赵宇,刘屹.能谱CT定量分析鉴别诊断肾透明细胞癌与肾脏乏脂肪血管平滑肌脂肪瘤的临床应用[J].临床军医杂志,2016,44(9):938-942.
[6]陈解南,张俊萍,刘铁峰,等.肾脏乏脂肪血管平滑肌脂肪瘤的临床病特征及CT表现[J].中国医学创新,2017,14(24):90-93.
[7]朱晓红,余永强,刘斌.乏脂肪肾脏血管平滑肌脂肪瘤与透明细胞癌的MSCT鉴别诊断[J].安徽医学,2017,38(6):766-768.
[8]黄丽军,张明波,陆志华.DWI在肾脏乏脂肪血管平滑肌脂肪瘤与透明细胞癌鉴别诊断的价值[J].中国CT与MRI杂志,2017,15(6):94-97.
[9]孟志华,黄钟情,周新,等.CT动态增强在肾脏乏脂肪血管平滑肌脂肪瘤与透明细胞癌中的鉴别诊断价值[J].汕头大学医学院学报,2017,30(4):228-229.
[10]尤国庆,李震,耿云平,等.乏脂肪型肾脏血管平滑肌脂肪瘤与肾脏透明细胞癌多排螺旋CT定量分析[J].实用医学杂志,2015,31(13):2151-2154.
[11]张爱伟,邱乾德,郑汉朋.肾脏乏脂肪血管平滑肌脂肪瘤的CT和MRI表现[J].医学影像学杂志,2014,24(2):268-271.
[12]卢贤忠,邓玉云,孟志华,等.肾脏乏脂肪血管平滑肌脂肪瘤的CT表现[J].中国当代医药,2017,24(18):63-65.